Modulatory Role of NTSR1 Antagonist SR48692 in HFD-Induced Thyroid Impairment in Mice: An In Vivo Study

Jump To References Section

Authors

  • Himanshu Pal
     Department of Zoology, University of Allahabad, Prayagraj - 211002, Uttar Pradesh ,IN
  • Pradeep Verma
     Department of Zoology, University of Allahabad, Prayagraj - 211002, Uttar Pradesh ,IN
  • Banalata Mohanty
     Department of Zoology, University of Allahabad, Prayagraj - 211002, Uttar Pradesh ,IN

DOI:

https://doi.org/10.18311/ti/2024/v31i3/36635

Keywords:

High-Fat Diet, Leptin, Neurotensin, SR48692, Thyroid Dysfunction

Abstract

Thyroid hormones are one of the crucial regulators of metabolism, especially lipid, and is linked with lipid metabolism dysregulation. High-Fat Diet (HFD) induces the secretion of Neurotensin (NTS), which enhances lipid absorption, and deposition, proportionately increases leptin. Increased leptin is associated with central leptin resistance and affects thyroid regulation which may lead to hypothyroidism. We hypothesized that HFD-induced increased NTS may cause dyslipidemia leading to thyroid alterations, which could be antagonized by the NTS receptor-1 (NTSR1) antagonist SR48692. Swiss albino mice (n = 24) were divided into two sets and fed with Standard Diet (SD) and HFD for 4 weeks. After that each set of mice were further divided into two groups and administered with 0.9% saline and SR48692 (100 μg/kg bw) intraperitoneally for 4 weeks and maintained as Group-I: (Control/SD), Group-II: (HFD), Group-IV: (HFD+SR48692), and Group-IV: (SD+SR48692). HFD-fed mice showed significantly decreased T3 and T4 with increased TSH and leptin, suggesting leptin-induced hypothyroidism, also reflected in the histological alterations observed in thyroid and adipose tissue. Co-treatment with SR48692 (HFD+SR48692) showed amelioration in the thyroid, as levels of T3, T4, TSH, and resensitization of leptin, were evident in histopathological analysis compared to HFD suggesting the therapeutic efficacy of SR48692 on thyroid impairment in dyslipidemia. Only SR48692-treated group showed an exacerbating effect.

Downloads

Download data is not yet available.

Downloads

Published

2024-05-16

How to Cite

Pal, H., Verma, P., & Mohanty, B. (2024). Modulatory Role of NTSR1 Antagonist SR48692 in HFD-Induced Thyroid Impairment in Mice: An <i>In Vivo</i> Study. Toxicology International, 31(3), 343–350. https://doi.org/10.18311/ti/2024/v31i3/36635

Issue

Volume 31, Issue 3, July-September 2024

Section

Articles

License

Copyright (c) 2024 P. Himanshu, V. Pradeep, M. Banalata

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC
Received 2024-02-19
Accepted 2024-04-12
Published 2024-05-16

 

References

Mullur R, Liu YY, Brent GA. Thyroid Hormone Regulation of Metabolism. Physiol Rev. 2014; 94:355–82. https://doi. org/10.1152/physrev.00030.2013 DOI: https://doi.org/10.1152/physrev.00030.2013

Su X, Peng H, Chen X, Wu X, Wang B. Hyperlipidemia and hypothyroidism. Clinica Chimica Acta. 2022; 527:61–70. https://doi.org/10.1016/j.cca.2022.01.006 DOI: https://doi.org/10.1016/j.cca.2022.01.006

Gully D, Canton M, Boigegrain R, Jeanjeant F, Molimard JC, Poncelett M, et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Nadl Acad Sci USA. 1993; 90:65–9. https://doi.org/10.1073/pnas.90.1.65 DOI: https://doi.org/10.1073/pnas.90.1.65

Drewe J, Mihailovic S, D’Amato M, Beglinger C. Regulation of fat-stimulated neurotensin secretion in healthy subjects. Journal of Clinical Endocrinology and Metabolism. 2008; 93(5):1964–70. https://doi.org/10.1210/jc.2007-2238 DOI: https://doi.org/10.1210/jc.2007-2238

Cooke JH, Patterson M, Patel SR, Smith KL, Ghatei MA, Bloom SR, et al. Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity. 2009; 17(6):1135–43. https://doi.org/10.1038/ oby.2008.652 DOI: https://doi.org/10.1038/oby.2008.652

Li J, Song J, Zaytseva YY, Liu Y, Rychahou P, Jiang K, et al. An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature. 2016; 533:411–5. https://doi.org/10.1038/ nature17662 DOI: https://doi.org/10.1038/nature17662

Ratner C, Skov LJ, Raida Z, Bächler T, Bellmann-Sickert K, Le Foll C, Sivertsen B, Dalbøge LS, Hartmann B, Beck-Sickinger AG, Madsen AN. Effects of peripheral neurotensin on appetite regulation and its role in gastric bypass surgery. Endocrinology. 2016; 157(9):3482-92. https://doi.org/10.1210/en.2016-1329 DOI: https://doi.org/10.1210/en.2016-1329

Barchetta I, Cimini FA, Capoccia D, Bertoccini L, Ceccarelli V, Chiappetta C, Leonetti F, Di Cristofano C, Silecchia G, Orho-Melander M, Melander O. Neurotensin is a lipidinduced gastrointestinal peptide associated with visceral adipose tissue inflammation in obesity. Nutrients. 2018; 10(4):526. https://doi.org/10.3390/nu10040526 DOI: https://doi.org/10.3390/nu10040526

Karakoc A, Ayvaz G, Taneri F, Toruner F, Yilmaz M, Cakir N, Arslan M. The effects of hypothyroidism in rats on serum leptin concentrations and leptin mRNA levels in adipose tissue and relationship with body fat composition. Endocrine Research. 2004; 30(2):247-55. https://doi. org/10.1081/ERC-120039569 DOI: https://doi.org/10.1081/ERC-120039569

Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER. Leptin and obesity: Role and clinical implication. Frontiers in Endocrinology. 2021; 12:585887. https://doi.org/10.3389/ fendo.2021.585887 DOI: https://doi.org/10.3389/fendo.2021.585887

Walczak K, Sieminska L. Obesity and thyroid axis. International Journal of Environmental Research and Public Health. 2021; 18(18). https://doi.org/10.3390/ ijerph18189434 DOI: https://doi.org/10.3390/ijerph18189434

Nillni EA, Vaslet C, Harris M, Hollenberg A, Bjorbaek C, Flier JS. Leptin regulates prothyrotropin-releasing hormone biosynthesis: Evidence for direct and indirect pathways. Journal of Biological Chemistry. 2000; 275(46):36124–33. https://doi.org/10.1074/jbc.M003549200 DOI: https://doi.org/10.1074/jbc.M003549200

Perello M, Çakir I, Cyr NE, Romero A, Stuart RC, Chiappini F, Hollenberg AN, Nillni EA. Maintenance of the thyroid axis during diet-induced obesity in rodents is controlled at the central level. American Journal of Physiology- Endocrinology and Metabolism. 2010; 299(6):E976-89. https://doi.org/10.1152/ajpendo.00448.2010 DOI: https://doi.org/10.1152/ajpendo.00448.2010

García-Solís P, García OP, Hernández-Puga G, Sánchez- Tusie AA, Sáenz-Luna CE, Hernández-Montiel HL, Solis-S JC. Thyroid hormones and obesity: A known but poorly understood relationship. Endokrynologia Polska. 2018; 69(3):292-303. https://doi.org/10.5603/EP.2018.0032 DOI: https://doi.org/10.5603/EP.2018.0032

Park HK, Ahima RS. Physiology of leptin: Energy homeostasis, neuroendocrine function and metabolism. Metabolism: clinical and experimental. 2015; 64(1):24–34. https://doi.org/10.1016/j.metabol.2014.08.004 DOI: https://doi.org/10.1016/j.metabol.2014.08.004

Shapiro A, Tümer N, Gao Y, Cheng KY, Scarpace PJ. Prevention and reversal of diet-induced leptin resistance with a sugar-free diet despite high fat content. British Journal of Nutrition. 2011; 106(3):390-97. https://doi. org/10.1017/S000711451100033X DOI: https://doi.org/10.1017/S000711451100033X

Mitra SP. Neurotensin and Neurotensin Receptors in health and diseases: A brief review. Indian Journal of Biochemistry and Biophysics. 2017; 54:7–23.

Nisato D, Guiraudou P, Barthrlrmy G, Gully D, Le Fur G. SR48692, a non-peptide neurotensin receptor antagonist, blocks the cardiovascular effects elicited by neurotensin in guinea pigs. Life Sciences. 1994; 54: 95–100. https://doi. org/10.1016/0024-3205(94)00411-0 DOI: https://doi.org/10.1016/0024-3205(94)00411-0

Osadchii O, Norton G, Deftereos D, Badenhorst D, Woodiwiss A. Impact and mechanisms of action of neurotensin on cardiac contractility in the rat left ventricle. European Journal of Pharmacology. 2005; 520(1-3):108-17. https://doi.org/10.1016/j.ejphar.2005.07.014 DOI: https://doi.org/10.1016/j.ejphar.2005.07.014

Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: Insulin resistance, fatty liver and Non- Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 mice fed a high fat diet. Journal of Clinical Biochemistry and Nutrition. 2010; 46(3):212–23. https://doi.org/10.3164/ jcbn.09-83 DOI: https://doi.org/10.3164/jcbn.09-83

Steinberg R, Rodier D, Mons G, Gully D, Le Fur G, Soubrié P. SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum. Neuropeptides. 1995; 29(1):27-31. https://doi.org/10.1016/0143-4179(95)90053-5 DOI: https://doi.org/10.1016/0143-4179(95)90053-5

Mishra AC, Mohanty B. Effects of lactational exposure of olanzapine and risperidone on hematology and lymphoid organs histopathology: A comparative study in mice neonates. European Journal of Pharmacology. 2010; 634(1– 3):170–7. https://doi.org/10.1016/j.ejphar.2010.02.014 DOI: https://doi.org/10.1016/j.ejphar.2010.02.014

Pandey SP, Mohanty B. Disruption of the hypothalamicpituitary- thyroid axis on co-exposures to dithiocarbamate and neonicotinoid pesticides: Study in a wildlife bird, Amandava amandava. Neuro Toxicology. 2017; 60:16–22. https://doi.org/10.1016/j.neuro.2017.02.010 DOI: https://doi.org/10.1016/j.neuro.2017.02.010

Kharbanda C, Bansal S, Aneja P. Role and significance of ghrelin and leptin in hunger, satiety, and energy homeostasis. Journal of the Scientific Society. 2022; 49(1):12. https://doi. org/10.4103/jss.jss_126_21 DOI: https://doi.org/10.4103/jss.jss_126_21

Gui X, DeGolier TF, Duke GE, Carraway RE. Neurotensin elevates hepatic bile acid secretion in chickens by a mechanism requiring an intact enterohepatic circulation. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology. 2000; 127(1):61-70. https:// doi.org/10.1016/S0742-8413(00)00126-2 DOI: https://doi.org/10.1016/S0742-8413(00)00126-2

Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine. 1995; 1(12):1311-4. https://doi. org/10.1038/nm1295-1311 DOI: https://doi.org/10.1038/nm1295-1311

Perello M, Stuart RC, Nillni EA. The role of intracerebroventricular administration of leptin in the stimulation of prothyrotropin releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology. 2006; 147(7):3296–306. https://doi.org/10.1210/en.2005- 1533 DOI: https://doi.org/10.1210/en.2005-1533

Zhu X, Cheng SY. New insights into regulation of lipid metabolism by thyroid hormone. Current opinion in endocrinology, diabetes, and obesity. 2010; 17(5):408. https://doi.org/10.1097/MED.0b013e32833d6d46 DOI: https://doi.org/10.1097/MED.0b013e32833d6d46

Elkalawy SA, Abo-Elnour RK, El Deeb DF, Yousry MM. Histological and immunohistochemical study of the effect of experimentally induced hypothyroidism on the thyroid gland and bone of male albino rats. Egyptian Journal of Histology. 2013; 36(1):92-102. https://doi.org/10.1097/01. EHX.0000424169.63765.ac DOI: https://doi.org/10.1097/01.EHX.0000424169.63765.ac

Shao SS, Zhao YF, Song YF, Xu C, Yang JM, Xuan SM, Yan HL, Yu CX, Zhao M, Xu J, Zhao JJ. Dietary high-fat lard intake induces thyroid dysfunction and abnormal morphology in rats. Acta Pharmacologica Sinica. 2014; 35(11):1411-20. https://doi.org/10.1038/aps.2014.82 DOI: https://doi.org/10.1038/aps.2014.82

Gui X, Dobner PR, Carraway RE. Endogenous neurotensin facilitates enterohepatic bile acid circulation by enhancing intestinal uptake in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2001; 281(6):G1413-22. https://doi.org/10.1152/ ajpgi.2001.281.6.G1413 DOI: https://doi.org/10.1152/ajpgi.2001.281.6.G1413

Andreoli MF, Donato J, Cakir I, Perello M. Leptin resensitisation: A reversion of leptin-resistant states. Journal of Endocrinology. 2019; 241(3):R81–96. https:// doi.org/10.1530/JOE-18-0606 DOI: https://doi.org/10.1530/JOE-18-0606

Hong J, Jia Y, Pan S, Jia L, Li H, Han Z, Cai D, Zhao R. Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice. Oncotarget. 2016; 7(35):56071. https://doi. org/10.18632/oncotarget.11267 DOI: https://doi.org/10.18632/oncotarget.11267

Karinch AM, Schmidt GL, Kauffman GL. Pretreatment with SR48692 has different effects on central neurotensininduced gastric mucosal defense and inhibition of gastric acid secretion in rats. Brain Research. 1998; 810:123–9. https://doi.org/10.1016/S0006-8993(98)00896-8 DOI: https://doi.org/10.1016/S0006-8993(98)00896-8

Croci T, Giudice A, Manara L, Gully D, Fur GL. Promotion by SR 48692 of gastric emptying and defaecation in rats suggesting a role of endogenous neurotensin. British Journal of Pharmacology. 1995; 115(3):383–4. https://doi. org/10.1111/j.1476-5381.1995.tb16343.x DOI: https://doi.org/10.1111/j.1476-5381.1995.tb16343.x

Babu G, Mohanty B. Neurotensin modulation of lipopolysaccharide induced inflammation of gut-liver axis: Evaluation using neurotensin receptor agonist and antagonist. Neuropeptides. 2023; 97:102297. https://doi. org/10.1016/j.npep.2022.102297 DOI: https://doi.org/10.1016/j.npep.2022.102297